ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,078 | +136.4% | 682 | +223.2% | 0.00% | – |
| Q2 2023 | $456 | +15100.0% | 211 | -83.5% | 0.00% | – |
| Q1 2023 | $3 | -92.1% | 1,281 | -92.7% | 0.00% | -100.0% |
| Q4 2022 | $38 | -100.0% | 17,443 | -57.4% | 0.00% | 0.0% |
| Q3 2022 | $123,000 | +98.4% | 40,965 | +87.8% | 0.00% | +100.0% |
| Q2 2022 | $62,000 | +1140.0% | 21,815 | +2032.5% | 0.00% | – |
| Q1 2022 | $5,000 | – | 1,023 | +3992.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 25 | -96.3% | 0.00% | – |
| Q3 2021 | $6,000 | +500.0% | 681 | +262.2% | 0.00% | – |
| Q2 2021 | $1,000 | -98.5% | 188 | -98.8% | 0.00% | -100.0% |
| Q1 2021 | $68,000 | +518.2% | 15,251 | +437.4% | 0.00% | – |
| Q4 2020 | $11,000 | +175.0% | 2,838 | +178.5% | 0.00% | – |
| Q3 2020 | $4,000 | -50.0% | 1,019 | -43.6% | 0.00% | -100.0% |
| Q4 2019 | $8,000 | -61.9% | 1,806 | -69.8% | 0.00% | 0.0% |
| Q3 2019 | $21,000 | – | 5,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 624,000 | $1,367 | 2.16% |
| Tikvah Management LLC | 1,350,833 | $2,958,324 | 1.41% |
| VR Adviser, LLC | 1,171,436 | $2,565,445 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 123,430 | $270,312 | 0.04% |
| FEDERATED HERMES, INC. | 5,231,600 | $11,457,204 | 0.03% |
| Alyeska Investment Group, L.P. | 1,378,747 | $3,019,456 | 0.03% |
| Walleye Capital LLC | 750,000 | $1,642,500 | 0.03% |
| Tower Research Capital LLC (TRC) | 17,443 | $38 | 0.00% |
| CITIGROUP INC | 428,460 | $938,327 | 0.00% |
| PFS Partners, LLC | 406 | $890 | 0.00% |